Search for: "ACTAVIS" Results 41 - 60 of 1,004
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2015, 7:15 am by Ingrid Mattson
The University of San Francisco School of Law hosts After Actavis: Litigating Reverse Payments Feb. 27, 2015. [read post]
15 Nov 2021, 3:00 am by D Daniel Sokol
'Sacrifice and Recoupment' in the Antitrust Analysis of Patent Settlements: Actavis Through the Lens of Brooke Group, Aspen Skiing, and Trinko Bryan Gant White & Case LLP Abstract Patent settlements are typically procompetitive, benefiting not only the settling parties but... [read post]
4 Oct 2016, 6:52 am
A wife complaints to the Qadi about her husband's impotence Artist: Hamse-i Atai (18th century Ottoman miniature) Source Wikipedia Mr Justice Birss: Actavis and Others v Eli Lilly and Another [2016] EWHC 1955 (Pat) (10 Aug 2016)  Although it is not spelt out anywhere in the 492 paragraphs and annexes to Mr Justice Birss's judgment, this complicated [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
4 Apr 2014, 9:32 am by Gene Quinn
The ultimate launch of Actavis’ product is, however, contingent upon Actavis receiving final approval from the U.S. [read post]
31 Aug 2006, 7:58 am
Actavis, based in Reykjavik, is offering Pliva investors 795 kuna a share, up from an offer of 735 kuna a share. [read post]
30 Aug 2010, 9:55 pm by Patent Docs
Actavis Elizabeth LLC, continuing a temporary injunction that had been granted by the District Court for the District of New Jersey one week earlier. [read post]
16 Sep 2018, 9:02 pm by Patent Docs
Actavis Elizabeth LLC handed down earlier this month. [read post]
1 Sep 2010, 9:59 pm by Patent Docs
Actavis Elizabeth LLC, granting Lilly's request for an injunction to prevent Defendants-Appellees from launching generic versions of Lilly's ADHD drug Strattera® until Lilly's appeal has been resolved. [read post]
15 Nov 2017, 4:00 am by Kimberly A. Kralowec
Actavis, Inc., ___ Cal.App.5th ___ (Nov. 6, 2017), the Court of Appeal (Fourth Appellate District, Division Three) considered whether the defendant pharmaceutical companies' CGL insurance policies required the insurers to defend a UCL "public prosecutor" action brought by Santa Clara and Orange Counties. [read post]
25 Mar 2013, 2:10 pm by Lisa Larrimore Ouellette
Actavis today (as I noted in my earlier post previewing the case), which involves when a brand name pharmaceutical company may make a "reverse payment" to a generic company as part of a settlement that delays the generic's market entry. [read post]
23 Mar 2010, 4:00 pm by mcarzima@imediainc.com
  While Actavis has not admitted any wrongdoing, the lawsuit alleged that Actavis reported inflated prices to drug industry reporting services. [read post]